Skip to content

Resources and Insights

Expert perspectives on how AI-powered solutions augment pharmacovigilance, regulatory, and clinical teams solving Pharma’s document workflow and authoring challenges.

Quartica MARS: the document co-authoring and workflow management all-in-one AI platform built for Pharma.

Built by Pharma experts, for Pharma experts

Built by a team of pharma technology and process experts, Quartica MARS is the only cross-functional platform already in use by major pharma companies. Deployed for more than 5 years with high adoption rates, it's already solving pharma specific needs.

Reduces Risk and Improves Efficiency

Reduce manual process risks with automatic document updates across teams, automatic global and local updates, and the audit readiness of a fully validated system. Reduces time spent on document production up to 55%.

No Silos. No piecemeal solutions.

Quartica MARS is a single platform that connects your documents. Rather than simply sitting in a file, your documents are now living, breathing assets that are connected to drive consistency and efficiency within a department or across the enterprise.

Asset 28Q Insights Logo no shape light

Featured

Explore all Quartica Insights

Asset 2Q Resources Logo no shape light
Icon Whitepaper or Report 900 x 528

Guide: Why AI Sandbox Pilots are Failing

Real-World Immersion is Essential for AI Authoring Success

This guide explains why traditional sandboxes fail, why synthetic data evaluations are misleading, and how an immersion-based evaluation model provides a more reliable, lower-risk path to production adoption.

Icon Whitepaper or Report 900 x 528

Guide: From Siloed Documents to Connected Intelligence

An AI Architecture and Compliance Framework for Life Sciences R&D - Medical Writing, Safety, and Regulatory Workflows

An architectural overview of how regulated AI should operate in Life Sciences R&D. The Quartica MARS Platform replaces siloed, document-centric workflows with a connected, governed intelligence layer that integrates data, documents, and human expertise. By embedding traceability, lifecycle awareness, and compliance-by-design, MARS enables scalable AI-assisted authoring across medical writing, safety, and regulatory domains without compromising inspection readiness or scientific control.

What can Quartica MARS do for you?

A Different Perspective on AI in Life Sciences: The powerful all-in-one workflow management and co-authoring platform build for Pharma, by Pharma and technology experts.

  • Reduce Compliance Risk

    Sleep better at night knowing that Quartica MARS is a validated system, complete with audit trails and thoughtful features that make audits a breeze.

  • Author and update all types of documents across your organization 

    Introducing IntelligentStreams™, Quartica MARS turns static regulatory and safety documents into living, governed intelligence. AI continuously understands and contextualizes content so it’s always current, compliant, and ready for use across submissions, safety reports, partner exchanges, and health authority interactions. 

  • Quartica MARS improves over time, specifically for you. 

    Each Quartica MARS implementation is customer-specific, using a secure Customer Adaptation Layer trained on your documents, SOPs, style guides, products, and systems. The validated platform doesn’t self-learn, but approved edits are captured and deployed through change control to continuously improve your version of MARS. 

  • Proof the system works at a much faster time to value 

    Sandboxes don’t work, and production-lite pilots are slow (but sometimes necessary), costly, and poor at proving AI value without real training. Quartica’s immersion workshop delivers fast proof by training MARS on your content and running a guided, two-day, hands-on evaluation with your team. 

  • Workflows built for your organization

    Quartica streamlines and automates your workflows using AI that understands your commitments, timelines, and stakeholders. It manages work end-to-end—assigning tasks, sending reminders, and tracking compliance—to ensure every obligation is met. 

  • Improves efficiency by more than 50% 

    Client case studies show Quartica MARS delivers over 55% efficiency in document creation, driven by major reductions in authoring, review, QC, and project timelines. The result is more time for your teams to focus on the science.

 

Schedule a 15 minute call with our experts.

It’s easy to get started. Spend 15 minutes with us to see if the Quartica MARS AI Platform can help your team work faster, stay compliant, and reduce risk.

 

 

Frequently Asked Questions

How does the Quartica MARS Platform support inspections, audits, and regulatory defensibility?

The Quartica MARS Platform is designed with auditability as a core principle. It maintains traceability between data, content, decisions, and approvals across the document lifecycle. Human oversight, version history, and decision ownership are visible and reviewable. This enables organizations to explain not only what was produced, but how and why it was produced.

What level of configuration or customization is required to implement the Quartica MARS Platform?

Quartica MARS is configurable rather than heavily customized. Core document structures, workflows, roles, review processes, templates, audit trails, and governance controls are available as part of the platform and can be adapted to each organization’s operating model. 

This allows customers to start with focused use cases, such as aggregate safety reports, PSMFs, RMPs, PV agreements, protocols, CSRs, or regulatory content, and expand over time without rebuilding the platform for each workflow. 

Implementation typically focuses on configuration, source data alignment, workflow design, validation support, user roles, training, and change management rather than custom software development. 

What types of organizations use the Quartica MARS Platform, and at what stage of development does it provide the most value?

Quartica MARS is used by life sciences organizations ranging from emerging, mid-size and large biopharma companies, CROs, and specialized life sciences service providers. 


MARS provides value when organizations need to scale regulated content production, improve consistency, reduce manual reconciliation, strengthen inspection readiness, or connect fragmented workflows across Safety, Clinical Medical Writing, Regulatory, and Quality functions. 

It is especially valuable for organizations with growing product portfolios, increasing report volumes, complex global/local processes, expanding vendor oversight needs, or a need to modernize regulated document workflows without replacing existing enterprise systems. 

Can AI really reduce headcount in pharma operations—or does it just shift the work?

In successful implementations, execution-heavy tasks are reduced while higher-value orchestration, oversight, and judgment roles increase. Organizations that redesign roles and workflows often see material efficiency gains. Those that do not typically see work shift rather than shrink.